UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Antisense Oligonucleotides: An Emerging Area in Drug Discovery and Development

Journal of clinical medicine, 2020-06, Vol.9 (6), p.2004

2020

Volltextzugriff (PDF)

In utero nanoparticle delivery for site-specific genome editing

Nature communications, 2018-06, Vol.9 (1), p.2481-11, Article 2481

2018

Volltextzugriff (PDF)

In vivo correction of anaemia in β-thalassemic mice by γPNA-mediated gene editing with nanoparticle delivery

Nature communications, 2016-10, Vol.7 (1), p.13304-14, Article 13304

2016

Volltextzugriff (PDF)

Direct targeting of amplified gene loci for proapoptotic anticancer therapy

Nature biotechnology, 2022-03, Vol.40 (3), p.325-334

2022

Volltextzugriff (PDF)

Anti-tumor Activity of miniPEG-γ-Modified PNAs to Inhibit MicroRNA-210 for Cancer Therapy

Molecular therapy. Nucleic acids, 2017-12, Vol.9 (C), p.111-119

2017

Volltextzugriff (PDF)

Abstract 1075: Chemically modified gamma PNAs targeting oncomiR-210 as a potential anticancer therapy

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (14_Supplement), p.1075-1075

2016

Volltextzugriff (PDF)

Nanoparticle‐mediated genome editing in single‐cell embryos via peptide nucleic acids

Bioengineering & translational medicine, 2023-05, Vol.8 (3), p.e10458-n/a

2023

Volltextzugriff (PDF)

Single-stranded γPNAs for in vivo site-specific genome editing via Watson-Crick recognition

Current gene therapy, 2014-01, Vol.14 (5), p.331-342

2014

Volltextzugriff (PDF)

Delivering Nucleic Acids to ADPKD Cystic Cells via a Nucleic Acid Binding and Cell-Penetrating Antibody: TH-PO405

Journal of the American Society of Nephrology, 2023-11, Vol.34 (11S), p.204-204

2023

Volltextzugriff (PDF)

Abstract 5801: Targeted delivery of Exatecan to tumors via a novel cell-penetrating, anti-DNA antibody

Cancer research (Chicago, Ill.), 2024-03, Vol.84 (6_Supplement), p.5801-5801

2024

Volltextzugriff (PDF)

Systemic Targeting of Therapeutic RNA to Tumors Via a Cell-Penetrating and RNA-Binding Antibody

Quijano, Elias

2023

Volltextzugriff (PDF)

Therapeutic Peptide Nucleic Acids: Principles, Limitations, and Opportunities

The Yale journal of biology & medicine, 2017-12, Vol.90 (4), p.583-598

2017

Volltextzugriff (PDF)

Degradable bioadhesive nanoparticles for prolonged intravaginal delivery and retention of elvitegravir

Biomaterials, 2017-11, Vol.144, p.144-154

2017

Volltextzugriff (PDF)

Abstract LB169: Systemic Administration of an antibody/RNA complex results in tumor specific delivery of immunostimulatory RNAs and tumor growth suppression in a mouse model of melanoma

Cancer research (Chicago, Ill.), 2021-07, Vol.81 (13_Supplement), p.LB169-LB169

2021

Volltextzugriff (PDF)

Abstract P135: Systemic targeting of a CNS tumor (medulloblastoma) using a novel cell-penetrating, nucleic acid binding, monoclonal antibody

Molecular cancer therapeutics, 2021-12, Vol.20 (12_Supplement), p.P135-P135

2021

Volltextzugriff (PDF)

Antispacer peptide nucleic acids for sequence-specific CRISPR-Cas9 modulation

Nucleic acids research, 2022-06, Vol.50 (10), p.e59-e59

2022

Volltextzugriff (PDF)

Nanoparticles that deliver triplex-forming peptide nucleic acid molecules correct F508del CFTR in airway epithelium

Nature communications, 2015-04, Vol.6 (1), p.6952-6952, Article 6952

2015

Volltextzugriff (PDF)

Fas ligand and nitric oxide combination to control smooth muscle growth while sparing endothelium

Biomaterials, 2019-08, Vol.212, p.28-38

2019

Volltextzugriff (PDF)

Poly(Lactic-co-Glycolic Acid) Nanoparticle Delivery of Peptide Nucleic Acids In Vivo

Methods in molecular biology (Clifton, N.J.), 2020, Vol.2105, p.261

2020

Volltextzugriff (PDF)

Direct targeting of amplified gene loci for pro-apoptotic anticancer therapy

Nature biotechnology, 2021-10, Vol.40 (3), p.325-334

2021

Volltextzugriff (PDF)

From in silico hit to long-acting late-stage preclinical candidate to combat HIV-1 infection

Proceedings of the National Academy of Sciences - PNAS, 2018-01, Vol.115 (4), p.E802-E811

2018

Volltextzugriff (PDF)

Identification of Optimized Peptide Nucleic Acid (PNA) Designs for Nuclease-Free Gene Editing in Sickle Cell Disease Hematopoietic Stem and Progenitor Cells (HSPCs)

Blood, 2019-11, Vol.134 (Supplement_1), p.4645-4645

2019

Volltextzugriff (PDF)

Systemic delivery of blood-brain barrier-targeted polymeric nanoparticles enhances delivery to brain tissue

Journal of drug targeting, 2015-01, Vol.23 (7-8), p.736-749

2015

Volltextzugriff (PDF)

Next-generation cell-penetrating antibodies for tumor targeting and RAD51 inhibition

Oncotarget, 2024-10, Vol.15 (1), p.699-713

2024

Volltextzugriff (PDF)

Abstract 755: Fas Ligand- and Nitric Oxide-Releasing Stent

Circulation research, 2019-08, Vol.125 (Suppl_1)

2019

Volltextzugriff (PDF)

1 – 25 von 51

Suche als RSS-Feed

Aktive Filter

ThemaChemistry, Multidisciplinary

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(41)
Mit Volltextzugriff
(38)

Publikationsform

Artikel
(50)
Dissertationen
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(22)
Humans
(13)
Life Sciences & Biomedicine
(13)
Animals
(10)
Nanoparticles
(10)
Female
(7)
Mice
(7)
Gene Editing
(6)
Nanoparticles - Administration & Dosage
(6)
Peptide Nucleic Acids
(6)
Technology
(6)
Nanoparticles - Chemistry
(5)
Peptide Nucleic Acids - Administration & Dosage
(5)
Peptides
(5)
Science & Technology - Other Topics
(5)
Engineering
(4)
Engineering, Biomedical
(4)
Genomes
(4)
Materials Science
(4)
Multidisciplinary Sciences
(4)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Antisense Oligonucleotides: An Emerging Area in Drug Discovery and Development

In utero nanoparticle delivery for site-specific genome editing

In vivo correction of anaemia in β-thalassemic mice by γPNA-mediated gene editing with nanoparticle delivery

Direct targeting of amplified gene loci for proapoptotic anticancer therapy

Anti-tumor Activity of miniPEG-γ-Modified PNAs to Inhibit MicroRNA-210 for Cancer Therapy

Abstract 1075: Chemically modified gamma PNAs targeting oncomiR-210 as a potential anticancer therapy

Nanoparticle‐mediated genome editing in single‐cell embryos via peptide nucleic acids

Single-stranded γPNAs for in vivo site-specific genome editing via Watson-Crick recognition

Delivering Nucleic Acids to ADPKD Cystic Cells via a Nucleic Acid Binding and Cell-Penetrating Antibody: TH-PO405

Abstract 5801: Targeted delivery of Exatecan to tumors via a novel cell-penetrating, anti-DNA antibody

Systemic Targeting of Therapeutic RNA to Tumors Via a Cell-Penetrating and RNA-Binding Antibody

Therapeutic Peptide Nucleic Acids: Principles, Limitations, and Opportunities

Degradable bioadhesive nanoparticles for prolonged intravaginal delivery and retention of elvitegravir

Abstract LB169: Systemic Administration of an antibody/RNA complex results in tumor specific delivery of immunostimulatory RNAs and tumor growth suppression in a mouse model of melanoma

Abstract P135: Systemic targeting of a CNS tumor (medulloblastoma) using a novel cell-penetrating, nucleic acid binding, monoclonal antibody

Antispacer peptide nucleic acids for sequence-specific CRISPR-Cas9 modulation

Nanoparticles that deliver triplex-forming peptide nucleic acid molecules correct F508del CFTR in airway epithelium

Fas ligand and nitric oxide combination to control smooth muscle growth while sparing endothelium

Poly(Lactic-co-Glycolic Acid) Nanoparticle Delivery of Peptide Nucleic Acids In Vivo

Direct targeting of amplified gene loci for pro-apoptotic anticancer therapy

From in silico hit to long-acting late-stage preclinical candidate to combat HIV-1 infection

Identification of Optimized Peptide Nucleic Acid (PNA) Designs for Nuclease-Free Gene Editing in Sickle Cell Disease Hematopoietic Stem and Progenitor Cells (HSPCs)

Systemic delivery of blood-brain barrier-targeted polymeric nanoparticles enhances delivery to brain tissue

Next-generation cell-penetrating antibodies for tumor targeting and RAD51 inhibition

Abstract 755: Fas Ligand- and Nitric Oxide-Releasing Stent

Aktive Filter

Suchergebnisse filtern